QHSLab and Town Total Compounding Announce Strategic Co-Marketing Partnership to Expand Market Opportunities and Drive Organic Growth
QHSLab Inc. (OTCQB: USAQ) has announced a strategic co-marketing partnership with Town Total Compounding to expand market opportunities and enhance patient care. The collaboration will introduce QHSLab's Integrated Service Program to over 200 primary care medical practices within Town Total's network.
The partnership integrates QHSLab's digital medicine assessments with Town Total's personalized prescription therapies for GLP-1s, Hormone Replacement Therapy, Allergen Immunotherapy, Pain Management, and Dermatological treatments. This initiative represents a non-dilutive growth strategy, allowing both companies to expand their market reach without additional capital investment.
The collaboration combines QHSLab's AI-driven screening tools with Town Total's compounding expertise to provide comprehensive healthcare solutions, focusing on improving patient outcomes through integrated care approaches.
QHSLab Inc. (OTCQB: USAQ) ha annunciato una partnership strategica di co-marketing con Town Total Compounding per espandere le opportunità di mercato e migliorare la cura del paziente. La collaborazione introdurrà il Programma di Servizi Integrati di QHSLab in oltre 200 studi medici di base all'interno della rete di Town Total.
La partnership integra le valutazioni di medicina digitale di QHSLab con le terapie prescritte personalizzate di Town Total per GLP-1, Terapia Ormonale Sostitutiva, Immunoterapia Allergene, Gestione del Dolore e trattamenti Dermatologici. Quest'iniziativa rappresenta una strategia di crescita non diluitiva, consentendo a entrambe le aziende di espandere la loro portata di mercato senza ulteriori investimenti di capitale.
La collaborazione combina gli strumenti di screening guidati dall'IA di QHSLab con l'expertise di preparazione di Town Total per fornire soluzioni sanitarie complete, concentrandosi sul miglioramento dei risultati per i pazienti attraverso approcci di assistenza integrata.
QHSLab Inc. (OTCQB: USAQ) ha anunciado una asociación estratégica de co-marketing con Town Total Compounding para ampliar las oportunidades de mercado y mejorar la atención al paciente. La colaboración presentará el Programa de Servicios Integrados de QHSLab a más de 200 consultas médicas de atención primaria dentro de la red de Town Total.
La asociación integra las evaluaciones de medicina digital de QHSLab con las terapias de prescripción personalizadas de Town Total para GLP-1, Terapia Hormonal Sustitutiva, Inmunoterapia para Alérgenos, Manejo del Dolor y tratamientos Dermatológicos. Esta iniciativa representa una estrategia de crecimiento no dilutiva, que permite a ambas empresas expandir su alcance en el mercado sin inversión de capital adicional.
La colaboración combina las herramientas de cribado impulsadas por IA de QHSLab con la experiencia en compuestos de Town Total para proporcionar soluciones de atención médica integrales, centrándose en mejorar los resultados para los pacientes a través de enfoques de atención integrada.
QHSLab Inc. (OTCQB: USAQ)는 Town Total Compounding와 전략적 공동 마케팅 파트너십을 발표하여 시장 기회를 확대하고 환자 치료를 향상시키기 위해 협력합니다. 이 협력은 Town Total의 네트워크 내에서 200개 이상의 1차 진료 의료 기관에 QHSLab의 통합 서비스 프로그램을 도입합니다.
파트너십은 QHSLab의 디지털 의학 평가와 Town Total의 GLP-1, 호르몬 대체 요법, 알레르겐 면역 요법, 통증 관리 및 피부 치료를 위한 맞춤형 처방 요법을 통합합니다. 이 이니셔티브는 자본 투자 없이 두 회사가 시장 점유율을 확대할 수 있는 비희석 성장 전략을 나타냅니다.
협력은 QHSLab의 AI 기반 스크리닝 도구와 Town Total의 복합 의약품 전문성을 결합하여 통합 치료 접근 방식을 통해 환자 결과를 개선하는 데 중점을 둔 종합적인 의료 솔루션을 제공합니다.
QHSLab Inc. (OTCQB: USAQ) a annoncé un partenariat stratégique de co-marketing avec Town Total Compounding pour élargir les opportunités de marché et améliorer les soins aux patients. Cette collaboration introduira le Programme de Services Intégrés de QHSLab dans plus de 200 pratiques médicales de soins primaires au sein du réseau de Town Total.
Le partenariat intègre les évaluations de médecine numérique de QHSLab avec les thérapies de prescription personnalisées de Town Total pour les GLP-1, la thérapie hormonale de substitution, l'immunothérapie allergénique, la gestion de la douleur et les traitements dermatologiques. Cette initiative représente une stratégie de croissance non dilutive, permettant aux deux entreprises d'élargir leur portée sur le marché sans investissement de capital supplémentaire.
La collaboration combine les outils de dépistage pilotés par IA de QHSLab avec l'expertise en formulation de Town Total pour fournir des solutions de santé complètes, en mettant l'accent sur l'amélioration des résultats pour les patients grâce à des approches intégrées des soins.
QHSLab Inc. (OTCQB: USAQ) hat eine strategische Co-Marketing-Partnerschaft mit Town Total Compounding angekündigt, um Marktchancen zu erweitern und die Patientenversorgung zu verbessern. Die Zusammenarbeit wird das integrierte Dienstleistungsprogramm von QHSLab in über 200 Hausarztpraxen im Netzwerk von Town Total einführen.
Die Partnerschaft integriert die digitalen medizinischen Bewertungen von QHSLab mit den personalisierten Verschreibungstherapien von Town Total für GLP-1, Hormonersatztherapie, Allergenen Immuntherapie, Schmerzmanagement und dermatologische Behandlungen. Diese Initiative stellt eine wachstumsorientierte Strategie dar, die es beiden Unternehmen ermöglicht, ihre Marktposition ohne zusätzliche Kapitalinvestitionen zu erweitern.
Die Zusammenarbeit kombiniert die KI-gesteuerten Screening-Tools von QHSLab mit der Fachkompetenz von Town Total im Bereich der Herstellung von Arzneimitteln, um umfassende Gesundheitslösungen bereitzustellen, wobei der Fokus auf der Verbesserung der Patientenergebnisse durch integrierte Versorgungsansätze liegt.
- Non-dilutive expansion strategy requiring no additional capital investment
- Access to 200+ primary care medical practices through Town Total's network
- Revenue growth potential through co-marketing partnership
- None.
- Expanding market reach to drive organic revenue growth without equity dilution
- Collaborating with AI-driven health assessments and customized pharmacy solutions to enhance patient care.
- Integrating Digital Health & Compounded Medications to bridge the gap between digital screening tools and patient-specific pharmaceutical treatments.
- Bringing Scalable, Data-Driven Healthcare to 200+ Primary Care Practices
WEST PALM BEACH, FL, Feb. 11, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (“the Company”) (OTCQB: USAQ), a leading provider of digital healthcare solutions and diagnostic technologies, has entered into a strategic co-marketing partnership with Town Total Compounding to expand market opportunities and enhance patient care through a comprehensive, integrated approach. This collaboration will introduce QHSLab's Integrated Service Program (ISP) to over 200 primary care medical practices within Town Total’s network, aligning digital medicine assessments with personalized prescription therapies for GLP-1s, Hormone Replacement Therapy (HRT), Allergen Immunotherapy, Pain Management, and Dermatological treatments.
By leveraging QHSLab's digital medicine technology and Town Total's expertise in patient-specific compounding, this mutually supportive partnership offers a non-dilutive growth opportunity for both organizations while expanding access to cutting-edge healthcare solutions.
A Non-Dilutive, Scalable Growth Strategy
This co-marketing initiative underscores both companies' commitment to expanding market reach without requiring additional capital investment. By integrating QHSLab’s digital health capabilities into Town Total’s established provider relationships, the partnership fosters organic business growth, enhances provider engagement, and drives better patient adherence and treatment outcomes.
Enhancing Patient Outcomes with Integrated Care
QHSLab's digital screening and assessment tools empower physicians with AI-driven insights and patient engagement resources, seamlessly integrating with Town Total Compounding’s ability to tailor treatments to individual patient needs. The partnership ensures a holistic approach to healthcare, optimizing both pharmacological and behavioral health interventions for better long-term patient outcomes.
"At Town Total Compounding, our mission is to help keep patients healthy by delivering personalized, high-quality medications," said Joseph Navarra, R.Ph., FACA, Head of Pharmacy and Owner of Town Total Compounding Center. "This collaboration with QHSLab allows us to offer primary care providers a seamless way to integrate digital medicine into their patient care plans, ensuring tailored treatment strategies that enhance clinical effectiveness."
"QHSLab’s partnership with Town Total represents a significant step forward in combining digital health innovation with customized pharmacy solutions," said Troy Grogan, CEO of QHSLab, Inc. "By providing primary care practices with advanced screening tools alongside specialized compounding services, we are creating a scalable, patient-centered approach to improving health outcomes—without the need for external financing or equity dilution."
For more information about QHSLab and our healthcare solutions, please visit www.qhslab.com.
About QHSLab, Inc.
QHSLab, Inc. (OTCQB: USAQ) is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. Digital healthcare allows doctors to assess patient responses quickly and effectively using advanced artificial intelligence algorithms. Digital healthcare can also remotely monitor patients’ vital signs and evaluate the effects of prescribed medicines and treatments on patients’ health through real-time data transferred from patient to doctor. QHSLab, Inc. also markets and sells point-of-care, rapid-response diagnostic tests used in the primary care practice. QHSLab, Inc.’s products and services are designed to help physicians improve patient monitoring and medical care while also increasing their revenues.
About Town Total Compounding Center
Town Total Compounding Center, based in Woodbury, NY, is a PCAB-accredited pharmacy specializing in sterile and non-sterile compounding. With over 30 years of experience, Joseph Navarra, R.Ph., FACA, FAPC has led the pharmacy’s commitment to customized patient care, serving prominent institutions such as NYU, Mount Sinai, and Montefiore Medical Center.
Forward-Looking Statements
Certain matters discussed in this press release are ‘forward-looking statements’ intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company’s statements regarding trends in the marketplace, future revenues, future products, and potential future results and acquisitions are examples of such forward-looking statements. Forward-looking statements are generally identified by words such as ‘may,’ ‘could,’ ‘believes,’ ‘estimates,’ ‘targets,’ ‘expects,’ or ‘intends,’ and other similar words that express risks and uncertainties. These statements are subject to numerous risks and uncertainties, including, but not limited to, the timing of the introduction of new products, the inherent discrepancy in actual results from estimates, projections, and forecasts made by management, regulatory delays, changes in government funding and budgets, and other factors, including general economic conditions, not within the Company’s control. The factors discussed herein and expressed from time to time in the Company’s filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release. The Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
Investor Relations Contact:
Brett Maas, Managing Principal, Hayden IR, LLC
brett@haydenir.com
646-536-7331
https://twitter.com/QHSLabInc
FAQ
What is the strategic partnership between QHSLab (USAQ) and Town Total Compounding?
How many medical practices will QHSLab (USAQ) reach through the Town Total partnership?
What services will be offered through the QHSLab (USAQ) and Town Total partnership?
How does the QHSLab (USAQ) partnership affect company financing?
